Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 (ENPP2), also known as Autotaxin (ATX), is a secreted enzyme with both phosphodiesterase and lysophospholipase D activity. Its main physiological function is the production of lysophosphatidic acid (LPA), a bioactive lipid that acts through GPCRs to stimulate cell proliferation, motility, chemotaxis, wound healing responses, angiogenesis, and other growth factor-like effects. ENPP2/LPA axis plays roles in tumor progression, inflammatory diseases, wound healing and bone mineralization.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 (ENPP2).